Enabling pseudokinases as potential drug targets.

Preuss, Franziska; Chatterjee, Deep; Dederer, Verena; Knapp, Stefan; Mathea, Sebastian

Preuss, Franziska; Chatterjee, Deep; Dederer, Verena; Knapp, Stefan; Mathea, Sebastian.

Afiliación

Preuss F; Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Frankfurt am Main, Germany; Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe-University, Frankfurt am Main, Germany.
Chatterjee D; Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Frankfurt am Main, Germany; Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe-University, Frankfurt am Main, Germany.
Dederer V; Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Frankfurt am Main, Germany; Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe-University, Frankfurt am Main, Germany.
Knapp S; Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Frankfurt am Main, Germany; Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe-University, Frankfurt am Main, Germany. Electronic address: knapp@pharmchem.uni-frankfurt.de.
Mathea S; Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Frankfurt am Main, Germany; Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe-University, Frankfurt am Main, Germany.

Methods Enzymol ; 667: 663-683, 2022.

Article en En | MEDLINE | ID: mdl-35525558

Asunto(s)

Conformación Molecular

Palabras clave

Baculovirus; Inhibitor screening; Medium-throughput cloning; Pseudokinase; X-ray crystallography

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Conformación Molecular Idioma: En Revista: Methods Enzymol Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google